Improvement of cross-border health services in oncological urology in Bialystok and Hrodna regions
About of project:
Period: 01.11.2019 – 31.10.2021
Budget: EUR 1,789,033.58 (total), EU contribution: EUR 1,610,130.22.
Funds provided to the Belarusian side: EUR 786,337.58, EU contribution: EUR 707,703.81
Implementing agency: Healthcare Institution “Hrodna University Clinic”
Partner: Autonomous Public Healthcare Organisation “Voivodship Hospital named after Jędrzej Śniadecki, Bialystok (Poland)
Locations: City and Region of Hrodna (Belarus); Podlaskie Voivodeship (Poland)
DescriptionThe growing number of new urologic cancer cases augments the need for surgical interventions. According to Belarus Cancer Registry, the number of prostate cancer cases in Belarus and Poland will grow by 29%, bladder cancer cases – by 22% by the year 2029. Enhanced healthcare accessibility and quality will contribute to improvements in urologic cancer diagnostics and surgeries.
Goal and objectives: The project mainly aims to raise the living standards of Bialystok and Hrodna Region residents by making the urologic cancer care system more accessible.
Specialized medical equipment will be procured for the hospitals for adopting new or improved treatment methods.
The project will support the public healthcare development by disseminating and exchanging the front-end practices and knowledge among medical doctors, and by conducting preventive patient examinations.
Expected outcomes: The project will provide for a reduction in complications and social costs of urologic cancer treatment as a result of a more correct and faster diagnostics and treatment process.
The project implementation process comprises the adoption of such new surgical interventions in the medical practices of the clinics, as laparoscopic prostatectomy, renal cancer cryoablation (Hrodna) and lymph node resection with fluorescence control, MRI biopsy/TRUS FusionProstat® (Bialystok).
Moreover, a number of medical services will also be improved: in Hrodna – laparoscopic nephrectomy, laparoscopic renal resection, laparoscopic adrenalectomy, photodynamic diagnostics for transurethral resection of bladder tumour (TURB); in Bialystok – 3D laparoscopy (nephrectomy, bladder resection and prostatectomy).
There are plans for holding four preventive events: doors-open days in both hospitals, aimed at cancer prevention. Several training brochures will be presented, a number of meetings with medical doctors, prostate-specific antigen (PSA) and U/S check-ups, as well consultations on cancer and urological conditions prevention will be organized during the events.
Contacts: Alexander Ragin, Project Coordinator, +375 152 96 91 39, mob. +375 29 117 77 03, e-mail: email@example.com